{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:25:06Z","timestamp":1762176306580},"reference-count":7,"publisher":"BMJ","issue":"6830","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1992,3,28]]},"DOI":"10.1136\/bmj.304.6830.831","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T12:16:37Z","timestamp":1238415397000},"page":"831-832","source":"Crossref","is-referenced-by-count":12,"title":["Missed neuroleptic malignant syndrome."],"prefix":"10.1136","volume":"304","author":[{"given":"D. S.","family":"Renwick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chandraker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1192\/bjp.150.6.752","article-title":"The neuroleptic malignant syndrome, so-called. A survey of the world literature","volume":"150","author":"Kellam, A.M.P.","year":"1987","unstructured":"Kellam AMP. The neuroleptic malignant syndrome, so-called. A survey of the world literature. BrJ Psychiany 1987;150:752-9.","journal-title":"BrJ Psychiany"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJM198507183130306","article-title":"Current concepts. Neuroleptic malignant syndrome","volume":"313","author":"Guze, B.H.; LR, Jr, Baxter","year":"1985","unstructured":"Guze BH, Baxter LR Jr. Current concepts. Neuroleptic malignant syndrome. N Englj Med 1985;313:163-6.","journal-title":"N Englj Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","article-title":"Neuroleptic malignant syndrome. A pathogenetic role for dopamine receptor blockade?","volume":"31","author":"Henderson, V.W.; Wooten, G.F.","year":"1981","unstructured":"Henderson VW, Wooten GF. Neuroleptic malignant syndrome. A pathogenetic role for dopamine receptor blockade? Neurology (NY) 1981;31:132-7.","journal-title":"Neurology (NY)"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(83)92620-X","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia","volume":"i:","author":"Caroff, S.N.","year":"1983","unstructured":"Caroff SN. Neuroleptic malignant syndrome and malignant hyperthermia. Lancet 1983;i:244.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1399-6576.1989.tb02990.x","article-title":"The association between the neuroleptic malignant syndrome and malignant hyperthermia","volume":"33","author":"Adnet, P.J.; Krivosic-Horber, R.M.; Admantidis, M.M.; Haudecouer, G.; AdnetBonte, C.A.; Saulnier, F.","year":"1989","unstructured":"Adnet PJ, Krivosic-Horber RM, Admantidis MM, Haudecouer G, AdnetBonte CA, Saulnier F, et al. The association between the neuroleptic malignant syndrome and malignant hyperthermia. Acta Scand Anaesthesiol 1989;33:676-80.","journal-title":"Acta Scand Anaesthesiol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0306-3623(90)90685-F","article-title":"Pathogenesis and treatment of the neuroleptic malignant syndrome","volume":"21","author":"Ebadi, M.; Pfeiffer, R.F.; Murrin, L.C.","year":"1990","unstructured":"Ebadi M, Pfeiffer RF, Murrin LC. Pathogenesis and treatment of the neuroleptic malignant syndrome. Gen Pharmacol 1990;21:367-86.","journal-title":"Gen Pharmacol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/archinte.1989.00390090009002","article-title":"Neuroleptic malignant syndrome: review of response to therapy","volume":"149","author":"Rosenberg, N.R.; Green, M.","year":"1989","unstructured":"Rosenberg NR, Green M. Neuroleptic malignant syndrome: review of response to therapy. Arch Intern Med 1989;149:1927-31.","journal-title":"Arch Intern Med"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.304.6830.831","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:48:50Z","timestamp":1601117330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.304.6830.831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,3,28]]},"references-count":7,"journal-issue":{"issue":"6830","published-print":{"date-parts":[[1992,3,28]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.304.6830.831","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,3,28]]}}}